(Alliance News) - Ulisse Biomed Spa announced Monday that its subsidiary Hyris Srl has entered into a partnership agreement with Mediline d.o.o. for the distribution of its proprietary solutions.

Mediline, the company wrote in a note, "is a leading company based in Slovenia, active in the Balkan area in the supply of products in the field of medical and pharmaceutical laboratory equipment for the healthcare, veterinary and food sectors."

The agreement, which is valid for one year and extendable for an additional year, provides for the designation of Mediline as a non-exclusive distributor of Hyris products and the proprietary Hyris System platform in Slovenia, Croatia, Bosnia and Herzegovina, Serbia, Albania, Montenegro, Kosovo, and North Macedonia.

"The agreement will enable UBM to preside over markets that have not yet been reached with proprietary solutions," the company points out, "guaranteeing customers access to a distinctive catalog for the different human healthcare, veterinary, food, and genetic testing research and development sectors.

Ulysses Biomed's stock trades in the green by 1.1 percent at EUR1.45 per share.

By Chiara Bruschi, Alliance News reporter

Comments and questions to redazione@alliancenews.com

Copyright 2024 Alliance News IS Italian Service Ltd. All rights reserved.